• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-world renal function among patients with multiple myeloma in the United States.

作者信息

Mikhael Joseph, Singh Erin, Rice Megan S

机构信息

Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, 85004, USA.

Sanofi, Cambridge, MA, 02142, USA.

出版信息

Blood Cancer J. 2021 May 21;11(5):99. doi: 10.1038/s41408-021-00492-6.

DOI:10.1038/s41408-021-00492-6
PMID:34021119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8140071/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f271/8140071/9f3a38c2c058/41408_2021_492_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f271/8140071/9f3a38c2c058/41408_2021_492_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f271/8140071/9f3a38c2c058/41408_2021_492_Fig1_HTML.jpg

相似文献

1
Real-world renal function among patients with multiple myeloma in the United States.美国多发性骨髓瘤患者的真实世界肾功能情况。
Blood Cancer J. 2021 May 21;11(5):99. doi: 10.1038/s41408-021-00492-6.
2
Outcomes of triple class (proteasome inhibitor, IMiDs and monoclonal antibody) refractory patients with multiple myeloma.三重耐药（蛋白酶体抑制剂、免疫调节药物及单克隆抗体）的多发性骨髓瘤患者的预后。
Leukemia. 2022 Mar;36(3):873-876. doi: 10.1038/s41375-021-01433-9. Epub 2021 Oct 11.
3
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation Therapies.新型疗法治疗多发性骨髓瘤患者的感染流行病学和风险。
Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):444-450.e3. doi: 10.1016/j.clml.2021.02.002. Epub 2021 Feb 18.
4
[Not Available].[无可用内容]
Praxis (Bern 1994). 2016;105(21):1255-1260. doi: 10.1024/1661-8157/a002493.
5
Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.新型多发性骨髓瘤治疗药物的肾毒性。
Clin J Am Soc Nephrol. 2017 Jan 6;12(1):176-189. doi: 10.2215/CJN.06100616. Epub 2016 Sep 21.
6
Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States.美国临床实践中多发性骨髓瘤患者的肾功能损害及肾毒性药物的使用情况。
Cancer Med. 2017 Jul;6(7):1523-1530. doi: 10.1002/cam4.1075. Epub 2017 Jun 14.
7
Update on proteasome inhibitors in multiple myeloma.多发性骨髓瘤中蛋白酶体抑制剂的最新进展
Clin Adv Hematol Oncol. 2014 Mar;12(3):179-81.
8
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.一名多发性骨髓瘤患者使用卡非佐米后出现的肾血栓性微血管病和足细胞病
BMC Nephrol. 2014 Sep 30;15:156. doi: 10.1186/1471-2369-15-156.
9
Reporting of adverse events of treatment interventions in multiple myeloma: an overview of systematic reviews.治疗干预多发性骨髓瘤不良事件报告：系统评价概述。
Ann Hematol. 2024 Aug;103(8):2681-2697. doi: 10.1007/s00277-023-05517-7. Epub 2023 Nov 8.
10
Recent advances in proteasome inhibitor-based cancer therapies.基于蛋白酶体抑制剂的癌症治疗的最新进展。
Curr Cancer Drug Targets. 2014;14(6):505. doi: 10.2174/1568009614666140805163018.

引用本文的文献

1
Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study).多发性骨髓瘤及相关肾肺损伤的药物治疗方法分析：大湾地区的一项回顾性真实世界注册研究（REPAIR研究）
Front Oncol. 2025 May 9;15:1547138. doi: 10.3389/fonc.2025.1547138. eCollection 2025.
2
Carfilzomib in multiple myeloma: unraveling cardiac toxicities - from mechanisms to diagnosis and management.卡非佐米治疗多发性骨髓瘤：揭示心脏毒性——从机制到诊断与管理
Front Pharmacol. 2025 Mar 27;16:1570017. doi: 10.3389/fphar.2025.1570017. eCollection 2025.
3

本文引用的文献

1
Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis.在有肾功能损害的复发/难治性多发性骨髓瘤患者中，伊沙妥昔单抗联合泊马度胺和地塞米松：ICARIA-MM 亚组分析。
Leukemia. 2021 Feb;35(2):562-572. doi: 10.1038/s41375-020-0868-z. Epub 2020 May 23.
2
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.多发性骨髓瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv52-iv61. doi: 10.1093/annonc/mdx096.
3
Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management.
Real-World Registry on the Pharmacotherapy of Multiple Myeloma and Associated Renal and Pulmonary Impairments in the Greater Gulf Region: Protocol for a Retrospective Real-World Data Study.
大湾地区多发性骨髓瘤及相关肾肺损伤药物治疗的真实世界注册研究：一项回顾性真实世界数据研究方案
JMIR Res Protoc. 2024 Apr 24;13:e49861. doi: 10.2196/49861.
4
Assessment of the implementation of accelerated drug marketing registration procedures for antineoplastic and immunomodulating agents in China: based on 2016-2022 review data.中国抗肿瘤和免疫调节药物加速上市注册程序实施情况评估：基于2016 - 2022年审评数据
Front Pharmacol. 2024 Mar 18;15:1345672. doi: 10.3389/fphar.2024.1345672. eCollection 2024.
5
An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment.复发/难治性多发性骨髓瘤合并肾功能损害患者的治疗选择概述
Ther Adv Hematol. 2022 Apr 2;13:20406207221088458. doi: 10.1177/20406207221088458. eCollection 2022.
多发性骨髓瘤：2016年诊断、风险分层及管理的最新进展
Am J Hematol. 2016 Jul;91(7):719-34. doi: 10.1002/ajh.24402.
4
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study.硼替佐米对肾功能损害患者的疗效与安全性：APEX 3期研究结果
Leukemia. 2008 Apr;22(4):842-9. doi: 10.1038/sj.leu.2405087. Epub 2008 Jan 17.
5
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database.肌酐校准对合并个体患者数据库中肾小球滤过率估算方程性能的影响。
Am J Kidney Dis. 2007 Jul;50(1):21-35. doi: 10.1053/j.ajkd.2007.04.004.
6
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.用标准化血清肌酐值表达肾脏疾病饮食改良研究方程以估算肾小球滤过率。
Clin Chem. 2007 Apr;53(4):766-72. doi: 10.1373/clinchem.2006.077180. Epub 2007 Mar 1.
7
Renal failure in multiple myeloma: incidence, correlations, and prognostic significance.多发性骨髓瘤中的肾衰竭：发病率、相关性及预后意义。
Leuk Lymphoma. 2007 Feb;48(2):337-41. doi: 10.1080/10428190601126602.
8
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.在肾脏病饮食改良研究方程中使用标准化血清肌酐值来估算肾小球滤过率。
Ann Intern Med. 2006 Aug 15;145(4):247-54. doi: 10.7326/0003-4819-145-4-200608150-00004.
9
Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma.肾衰竭与多发性骨髓瘤：肾衰竭的发病机制与治疗以及潜在骨髓瘤的管理
Blood Rev. 1999 Jun;13(2):79-90. doi: 10.1016/s0268-960x(99)90014-0.